Literature DB >> 30053219

Which scoring method depicts spinal radiographic damage in early axial spondyloarthritis best? Five-year results from the DESIR cohort.

Sofia Ramiro1,2, Pascal Claudepierre3,4, Alexandre Sepriano1,5, Miranda van Lunteren1, Anna Molto6,7, Antoine Feydy8, Maria Antonietta d'Agostino9,10, Damien Loeuille11, Maxime Dougados6,7, Monique Reijnierse12, Désirée van der Heijde1.   

Abstract

Objective: To compare the performance of different spinal radiographic damage scoring methods in patients with early axial spondyloarthritis (axSpA).
Methods: Five-year spinal radiographs from the DESIR cohort were scored by three readers (averaged) for the calculation of the Stoke AS Spine Score (SASSS), modified Stoke Ankylosing Spondylitis Spine Score (mSASSS), Radiographic AS Spinal Score (RASSS), BASRI-spine and BASRI-total, and following the OMERACT filter, scores were compared according to truth, discrimination (reliability and sensitivity to change) and feasibility. The proportion of patients with a net change > smallest detectable change and >1 was calculated. The proportion of total variance explained by the patient (true variance) was calculated for the change scores as a measure of reliability, using analysis of variance.
Results: In total 699 patients were included. Five-year net changes > smallest detectable change (>1) were: RASSS 17% (17%), mSASSS 12% (12%), BASRI-spine and BASRI-total 12% (9%), SASSS 11% (11%). The mSASSS and the RASSS performed the best in terms of capturing the signal (positive change) related to noise (negative change). The proportion of variance explained by the patient was highest for the mSASSS and RASSS (85% for both 5-year progression scores vs 50-55% for other methods). The proportion of patient variance in the thoracic segment of the RASSS was unsatisfactory (46% for progression).
Conclusion: The existing scoring methods to assess spinal radiographic damage performed well in early phases of axSpA. The mSASSS and RASSS captured most change. There was no clear gain in additionally scoring the thoracic spine for the RASSS. The mSASSS remains the most sensitive and valid scoring method in axSpA, including early phases of the disease.

Entities:  

Mesh:

Year:  2018        PMID: 30053219     DOI: 10.1093/rheumatology/key185

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis.

Authors:  Paras Karmacharya; Ali Duarte-Garcia; Maureen Dubreuil; M Hassan Murad; Ravi Shahukhal; Pragya Shrestha; Elena Myasoedova; Cynthia S Crowson; Kerry Wright; John M Davis
Journal:  Arthritis Rheumatol       Date:  2020-04-01       Impact factor: 10.995

Review 2.  The role of imaging in the diagnosis and management of axial spondyloarthritis.

Authors:  Walter P Maksymowych
Journal:  Nat Rev Rheumatol       Date:  2019-10-07       Impact factor: 20.543

3.  Imaging Outcomes for Axial Spondyloarthritis and Sensitivity to Change: A Five-Year Analysis of the DESIR Cohort.

Authors:  Alexandre Sepriano; Sofia Ramiro; Désirée van der Heijde; Maxime Dougados; Pascal Claudepierre; Antoine Feydy; Monique Reijnierse; Damien Loeuille; Robert Landewé
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-10       Impact factor: 5.178

4.  Spinal Radiographic Progression in Early Axial Spondyloarthritis: Five-Year Results From the DESIR Cohort.

Authors:  Sofia Ramiro; Désirée van der Heijde; Alexandre Sepriano; Miranda van Lunteren; Anna Moltó; Antoine Feydy; Maria Antonietta d'Agostino; Damien Loeuille; Maxime Dougados; Monique Reijnierse; Pascal Claudepierre
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-14       Impact factor: 4.794

5.  Inflammation of the Sacroiliac Joints and Spine and Structural Changes on Magnetic Resonance Imaging in Axial Spondyloarthritis: Five-Year Data From the DESIR Cohort.

Authors:  Alexandre Sepriano; Sofia Ramiro; Robert Landewé; Anna Moltó; Pascal Claudepierre; Daniel Wendling; Maxime Dougados; Désirée van der Heijde
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12-28       Impact factor: 5.178

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.